Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Effect of mycophenolate and rapamycin on renal fibrosis in lupus nephritis.

Zhang C, Chan CCY, Cheung KF, Chau MKM, Yap DYH, Ma MKM, Chan KW, Yung S, Chan TM.

Clin Sci (Lond). 2019 Aug 5;133(15):1721-1744. doi: 10.1042/CS20190536. Print 2019 Aug 15.

PMID:
31358596
2.

Long-term data on entecavir treatment for treatment-naive or lamivudine-resistant chronic hepatitis B infection in kidney transplant recipients.

Yap DYH, Tang C, Fung JYY, Seto WK, Ma MKM, Choy BY, Chan TM.

Transpl Infect Dis. 2019 Jul 8:e13143. doi: 10.1111/tid.13143. [Epub ahead of print]

PMID:
31282041
3.

In Vitro and In Vivo Renoprotective Effects of Telbivudine in Chronic Hepatitis B Patients Receiving Nucleotide Analogue.

Mak LY, Liu SH, Yap DY, Seto WK, Wong DK, Fung J, Chan TM, Lai CL, Yuen MF.

Dig Dis Sci. 2019 Jul 6. doi: 10.1007/s10620-019-05717-0. [Epub ahead of print]

PMID:
31280390
4.

Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy Showing Thrombotic Microangiopathy.

Li C, Yap DYH, Chan G, Wen YB, Li H, Tang C, Li XM, Li XW, Chan TM.

J Rheumatol. 2019 Mar 15. pii: jrheum.180773. doi: 10.3899/jrheum.180773. [Epub ahead of print]

PMID:
30877215
5.

A young Chinese man with nephrotic syndrome due to lipoprotein glomerulopathy.

Lui DTW, Lee ACH, Yap DYH, Chan GSW, Tan KCB.

J Clin Lipidol. 2019 Mar - Apr;13(2):251-253. doi: 10.1016/j.jacl.2018.12.004. Epub 2018 Dec 19.

PMID:
30685233
6.

Lupus nephritis: An update on treatments and pathogenesis.

Yap DY, Yung S, Chan TM.

Nephrology (Carlton). 2018 Oct;23 Suppl 4:80-83. doi: 10.1111/nep.13469. Review.

PMID:
30298658
7.

Longterm Data on Sirolimus Treatment in Patients with Lupus Nephritis.

Yap DYH, Tang C, Chan GCW, Kwan LPY, Ma MKM, Mok MMY, Chan TM.

J Rheumatol. 2018 Dec;45(12):1663-1670. doi: 10.3899/jrheum.180507. Epub 2018 Oct 1.

PMID:
30275264
8.

Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis.

Yap DYH, Tam CH, Yung S, Wong S, Tang CSO, Mok TMY, Yuen CKY, Ma MKM, Lau CS, Chan TM.

Nephrol Dial Transplant. 2018 Sep 11. doi: 10.1093/ndt/gfy284. [Epub ahead of print]

PMID:
30215770
9.

A Longitudinal Study on the Prevalence and Risk Factors for Depression and Anxiety, Quality of Life, and Clinical Outcomes in Incident Peritoneal Dialysis Patients.

Mok MMY, Liu CKM, Lam MF, Kwan LPY, Chan GCW, Ma MKM, Yap DYH, Chiu F, Choy CBY, Tang SCW, Chan TM.

Perit Dial Int. 2019 Jan-Feb;39(1):74-82. doi: 10.3747/pdi.2017.00168. Epub 2018 Jul 10.

PMID:
29991560
10.

Palliative Care Consultation in Advanced Chronic Kidney Disease with Pain.

Chan KY, Yap DYH, Yip T, Sham MK, Lui SL, Chan TM.

J Palliat Med. 2018 Jun;21(6):809-814. doi: 10.1089/jpm.2017.0505. Epub 2018 Mar 12.

PMID:
29596025
11.

Preemptive immunosuppressive treatment for asymptomatic serological reactivation may reduce renal flares in patients with lupus nephritis: a cohort study.

Yap DYH, Kwan LPY, Ma MKM, Mok MMY, Chan GCW, Chan TM.

Nephrol Dial Transplant. 2019 Mar 1;34(3):467-473. doi: 10.1093/ndt/gfy024.

PMID:
29509932
12.

Non-invasive assessment of kidney allograft fibrosis with shear wave elastography: A radiological-pathological correlation analysis.

Ma MK, Law HK, Tse KS, Chan KW, Chan GC, Yap DY, Mok MM, Kwan LP, Tang SC, Choy BY, Chan TM.

Int J Urol. 2018 May;25(5):450-455. doi: 10.1111/iju.13536. Epub 2018 Feb 14.

13.

Genotype 4 hepatitis E virus is a cause of chronic hepatitis in renal transplant recipients in Hong Kong.

Sridhar S, Chan JFW, Yap DYH, Teng JLL, Huang C, Yip CCY, Hung IFN, Tang SCW, Lau SKP, Woo PCY, Yuen KY.

J Viral Hepat. 2018 Feb;25(2):209-213. doi: 10.1111/jvh.12799. Epub 2017 Nov 13. No abstract available.

PMID:
28984015
14.

Longterm Data on Disease Flares in Patients with Proliferative Lupus Nephritis in Recent Years.

Yap DYH, Tang C, Ma MKM, Mok MMY, Chan GCW, Kwan LPY, Chan TM.

J Rheumatol. 2017 Sep;44(9):1375-1383. doi: 10.3899/jrheum.170226. Epub 2017 Jul 1.

PMID:
28668803
15.

Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis.

Yung S, Yap DY, Chan TM.

F1000Res. 2017 Jun 13;6:874. doi: 10.12688/f1000research.10445.1. eCollection 2017. Review.

16.

Mycobacterium chlorophenolicum: An uncommon cause of peritonitis in a peritoneal dialysis patient.

Chan GCW, Mok MMY, Hung DLL, Chan JFW, Kwan LPY, Ma MKM, Yap DYH, Tang SCW.

Nephrology (Carlton). 2017 Jun;22(6):498-499. doi: 10.1111/nep.12820. No abstract available.

PMID:
28429521
17.

Colossal renal allograft hydronephrosis causing abdominal distension.

Chan GC, Yap DY, Kwan LP, Mok MM, Ma MK, Chu FS, Tang SC.

Nephrology (Carlton). 2017 May;22(5):420-421. doi: 10.1111/nep.12817. No abstract available.

PMID:
28378534
18.

Annexin II-binding immunoglobulins in patients with lupus nephritis and their correlation with disease manifestations.

Cheung KF, Yung S, Chau MK, Yap DY, Chan KW, Lee CK, Tang CS, Chan TM.

Clin Sci (Lond). 2017 Apr 25;131(8):653-671. doi: 10.1042/CS20160732. Epub 2017 Feb 9.

PMID:
28183811
19.

A Rare Case of Famotidine-Induced Delirium in a Peritoneal Dialysis Patient.

Chan GC, Lee KM, Kwan LP, Mok MM, Ma MK, Yap DY, Tang SC.

Perit Dial Int. 2017 1-2;37(1):118-120. doi: 10.3747/pdi.2016.00145. Review.

PMID:
28153970
20.

Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis.

Yap DY, Seto WK, Fung J, Chok SH, Chan SC, Chan GC, Yuen MF, Chan TM.

Dig Liver Dis. 2017 Feb;49(2):202-206. doi: 10.1016/j.dld.2016.11.001. Epub 2016 Nov 10.

PMID:
27876501
21.

Binding of anti-dsDNA antibodies to proximal tubular epithelial cells contributes to renal tubulointerstitial inflammation.

Yung S, Ng CY, Au KY, Cheung KF, Zhang Q, Zhang C, Yap DY, Chau MK, Chan TM.

Clin Sci (Lond). 2017 Jan 1;131(1):49-67. Epub 2016 Oct 25.

PMID:
27780843
22.

Epidemiology and Clinical Characteristics of Acinetobacter Peritoneal Dialysis-Related Peritonitis in Hong Kong-With a Perspective on Multi-Drug and Carbapenem Resistance.

Li PH, Cheng VC, Yip T, Yap DY, Lui SL, Lo WK.

Perit Dial Int. 2017 Mar-Apr;37(2):177-182. doi: 10.3747/pdi.2016.00123. Epub 2016 Sep 28.

PMID:
27680764
23.

The microprocessor component, DGCR8, is essential for early B-cell development in mice.

Brandl A, Daum P, Brenner S, Schulz SR, Yap DY, Bösl MR, Wittmann J, Schuh W, Jäck HM.

Eur J Immunol. 2016 Dec;46(12):2710-2718. doi: 10.1002/eji.201646348. Epub 2016 Oct 5.

24.

Risk factors and prognosis of late acute rejection in Chinese kidney transplant recipients.

Mok MMY, Ma MKM, Yap DYH, Chan GSW, Lam MF, Kwok JSY, Kwan LPY, Chan GCW, Choy CBY, Tang SCW, Chan TM.

Nephrology (Carlton). 2017 Dec;22(12):985-992. doi: 10.1111/nep.12917.

PMID:
27587222
25.

Lupus Nephritis in Asia: Clinical Features and Management.

Yap DY, Chan TM.

Kidney Dis (Basel). 2015 Sep;1(2):100-9. doi: 10.1159/000430458. Epub 2015 Aug 5. Review.

26.

Excessive watermelon consumption causing hyperkalaemia and increased symptom burden of an end stage renal disease patient.

Chan KY, Yap DY, Li CW, Cheng HW, Au HY.

Nephrology (Carlton). 2016 Aug;21(8):721. doi: 10.1111/nep.12655. No abstract available.

PMID:
27436619
27.

Disenfranchised Grief after the Death of a Palliative Care Colleague.

Cheung KC, Chan KY, Yap DY.

J Palliat Med. 2016 Sep;19(9):905. doi: 10.1089/jpm.2016.0164. Epub 2016 May 5. No abstract available.

PMID:
27149023
28.

Kidney Allograft Abscess: An Unusual Cause of Peritonitis in a Patient on Peritoneal Dialysis.

Yap DY, Mok MM, Chan GC, Choy BY, Chan TM.

Nephrology (Carlton). 2016 Mar;21(3):266. doi: 10.1111/nep.12568. No abstract available.

PMID:
26818220
29.

Enhanced Psychosocial Support for Caregiver Burden for Patients With Chronic Kidney Failure Choosing Not to Be Treated by Dialysis or Transplantation: A Pilot Randomized Controlled Trial.

Chan KY, Yip T, Yap DY, Sham MK, Wong YC, Lau VW, Li CW, Cheng BH, Lo WK, Chan TM.

Am J Kidney Dis. 2016 Apr;67(4):585-92. doi: 10.1053/j.ajkd.2015.09.021. Epub 2015 Nov 6.

PMID:
26549852
30.

Burkholderia cepacia Exit-Site Infection in Peritoneal Dialysis Patients-Clinical Characteristics and Treatment Outcomes.

Yap DY, Chan JF, Yip T, Mok MM, Kwan LP, Lo WK, Chan TM.

Perit Dial Int. 2016 Jul-Aug;36(4):390-4. doi: 10.3747/pdi.2015.00122. Epub 2015 Oct 22.

31.

Use of telbivudine in kidney transplant recipients with chronic hepatitis B virus infection: A preliminary experience.

Yap DY, Chan TM.

Nephrology (Carlton). 2016 May;21(5):438-41. doi: 10.1111/nep.12651.

PMID:
26484932
32.

Arthrobacter sanguinis: an uncommon cause of peritonitis in a peritoneal dialysis patient.

Yap DY, Tse H, Mok MM, Chan GC, Yip T, Lui SL, Lo WK, Chan TM.

Nephrology (Carlton). 2015 Nov;20(11):868. doi: 10.1111/nep.12513. No abstract available.

PMID:
26443074
33.

Proteinuria is associated with sleep apnea in chronic kidney disease.

Chan GC, Lam B, Yap DY, Ip MS, Lai KN, Tang SC.

Nephrol Dial Transplant. 2016 May;31(5):772-9. doi: 10.1093/ndt/gfv306. Epub 2015 Aug 26.

PMID:
26311214
34.

Serum level of proximal renal tubular epithelial cell-binding immunoglobulin G in patients with lupus nephritis.

Yap DY, Yung S, Zhang Q, Tang C, Chan TM.

Lupus. 2016 Jan;25(1):46-53. doi: 10.1177/0961203315598018. Epub 2015 Aug 6.

PMID:
26251400
35.

Severe liver failure due to influenza A infection in a hemodialysis patient.

Mok MM, Cheng VC, Lui SL, Kwan LP, Chan GC, Yap DY, Chan TM, Lo WK.

Hemodial Int. 2016 Jan;20(1):E16-8. doi: 10.1111/hdi.12335. Epub 2015 Jul 22.

PMID:
26198843
36.

Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.

Ciurea SO, Thall PF, Milton DR, Barnes TH, Kongtim P, Carmazzi Y, López AA, Yap DY, Popat U, Rondon G, Lichtiger B, Aung F, Afshar-Kharghan V, Ma Q, Fernández-Viña M, Champlin RE, Cao K.

Biol Blood Marrow Transplant. 2015 Aug;21(8):1392-8. doi: 10.1016/j.bbmt.2015.05.001. Epub 2015 May 15.

37.

Pathogenesis of renal disease in systemic lupus erythematosus--the role of autoantibodies and lymphocytes subset abnormalities.

Yap DY, Lai KN.

Int J Mol Sci. 2015 Apr 9;16(4):7917-31. doi: 10.3390/ijms16047917. Review.

38.

Progressive outer retinal necrosis in a renal transplant recipient: a rare treatment success.

Chan GC, Yap DY, Kwan LP, Chan JF, Iu LP, Wong IY, Tang SC.

Transpl Infect Dis. 2015 Jun;17(3):396-9. doi: 10.1111/tid.12385. Epub 2015 May 19.

PMID:
25845801
39.

Mesangial cell-binding activity of serum immunoglobulin g in patients with lupus nephritis.

Yap DY, Yung S, Zhang Q, Tang C, Chan TM.

PLoS One. 2014 Jul 9;9(7):e101987. doi: 10.1371/journal.pone.0101987. eCollection 2014.

40.

Long-term data on tacrolimus treatment in lupus nephritis.

Yap DY, Ma MK, Mok MM, Kwan LP, Chan GC, Chan TM.

Rheumatology (Oxford). 2014 Dec;53(12):2232-7. doi: 10.1093/rheumatology/keu265. Epub 2014 Jul 4.

PMID:
24996908
41.

Burkholderia cepacia-an uncommon cause of exit-site infection in a peritoneal dialysis patient.

Yap DY, Choy CB, Mok MM, Wong TK, Chan TM.

Perit Dial Int. 2014 Jun;34(4):471-2. doi: 10.3747/pdi.2013.00090. No abstract available.

42.

Entecavir treatment in kidney transplant recipients infected with hepatitis B.

Yap DY, Yung S, Tang CS, Seto WK, Ma MK, Mok MM, Kwan LP, Chan GC, Choy BY, Yuen MF, Chan TM.

Clin Transplant. 2014 Sep;28(9):1010-5. doi: 10.1111/ctr.12410. Epub 2014 Jul 17.

PMID:
24974788
43.

Treatment of lupus nephritis: practical issues in Asian countries.

Yap DY, Chan TM.

Int J Rheum Dis. 2015 Feb;18(2):138-45. doi: 10.1111/1756-185X.12423. Epub 2014 Jun 26. Review.

PMID:
24965809
44.

Reduction of acute hospital admissions and improvement in outpatient attendance by intensified renal palliative care clinic follow-up: the Hong Kong experience.

Chan KY, Cheng HW, Yap DY, Yip T, Li CW, Sham MK, Wong YC, Lau WK.

J Pain Symptom Manage. 2015 Jan;49(1):144-9. doi: 10.1016/j.jpainsymman.2014.04.010. Epub 2014 May 23.

PMID:
24863154
45.

Secondary atypical mycobacterial infection after peritoneal catheter removal.

Mok MM, Ma MK, Yap DY, Chan TM, Lam FM.

Int Wound J. 2016 Oct;13(5):1021-2. doi: 10.1111/iwj.12284. Epub 2014 May 14. No abstract available.

PMID:
24827937
46.

Chronotropic incompetence, echocardiographic abnormalities and exercise intolerance in renal transplant recipients.

Ma MK, Zuo ML, Yap DY, Mok MM, Kwan LP, Chan GC, Siu DC, Chan TM.

J Nephrol. 2014 Aug;27(4):451-6. doi: 10.1007/s40620-014-0091-y. Epub 2014 Apr 23.

PMID:
24756970
47.

Cortical necrosis in a kidney transplant recipient due to leptospirosis.

Yap DY, Chan GS, Chan KW, Kwan LP, Wong WT, Lam MF, Chan TM.

Nephrology (Carlton). 2014 Apr;19(4):257-8. doi: 10.1111/nep.12189. No abstract available.

PMID:
24661859
48.

Hydralazine-induced toxic epidermal necrolysis in a patient on continuous ambulatory peritoneal dialysis.

Chan JC, Yap DY, Yeung CK.

J Clin Pharm Ther. 2014 Jun;39(3):322-4. doi: 10.1111/jcpt.12141. Epub 2014 Mar 4.

PMID:
24588409
49.

Evolution of hepatitis B management in kidney transplantation.

Yap DY, Chan TM.

World J Gastroenterol. 2014 Jan 14;20(2):468-74. doi: 10.3748/wjg.v20.i2.468. Review.

50.

Serum immunoglobulin G level in patients with lupus nephritis and the effect of treatment with corticosteroids and mycophenolate mofetil.

Yap DY, Yung S, Ma MK, Mok MM, Kwan LP, Chan GC, Chan TM.

Lupus. 2014 Jun;23(7):678-83. doi: 10.1177/0961203314525248. Epub 2014 Feb 19.

PMID:
24554708

Supplemental Content

Support Center